This outstanding book covers all aspects of new developments in the field of basic electrophysiology, cardiac pacing, implantable defibrillators and socioeconomic aspects related to these topics. The section on electrophysiology provides a comprehensive overview of basic hardware equipment, sudden death, heart rate variability, signal averaged ECG, RF catheter ablation and clinical decision making. The section on pacing includes overviews on new lead developments, pacing in cardiomyopathy, as well as VVIR & DDIR pacing and automatic mode switching. Finally the section on implantable defibrillator provides a detailed view of clinical and technical aspects of third generation devices. All chapters have been written by world experts in their fields and each chapter is fully illustrated with tables, ECG recordings and black and white photographs.
The book is highly recommended for nurses, technicians, bioengineers, cardiologists, cardiovascular surgeons, health authorities and for all who are involved in the field of pacing and electrophysiology.

Zusammenfassung
Covering aspects of new developments in the field of basic electrophysiology, cardiac pacing and implantable defibrillators, this text also addresses socioeconomic aspects related to thse topics.

Inhalt

Foreword. Part One: Electrophysiology. 1. Equipment for the electrophysiology laboratory; possibilities and limitations. 2. Vasovagal syncope: clinical presentation, classification and management. 3. Classification of antiarrhythmic drugs in relation to mechanisms of arrhythmias. 4. Electrophysiological characteristics in arrhythmogenic right ventricular dysplasia and dilated cardiomyopathies. 5. Classification of death in patients under antiarrhythmic treatment. 6. Heart rate variability. Methodology and physiological basis. 7. Heart rate variability and QT interval: their relationship with the cardiac frequency. 8. Role of dynamic QT interval in Holter tapes to stratify risk in postmyocardial infarction patients. 9. Heart rate variability in patients with angina pectoris. 10. Time and frequency domain analysis of heart rate variability after myocardial infarction. 11. Signal averaged ECG. Technical principles, possibilities and limitations. 12. Optimizing the predictive value of the signal-averaged ECG for serious arrhythmic events in the post-infarction period. 13. Signal-averaged analysis of the P wave: possible applications in different settings. 14. Late potentials during acute myocardial ischaemia. 15. Radiofrequency catheter ablation in the treatment of supraventricular tachycardias. 16. Anatomical versus electrophysiological approaches for ablation of the slow pathway in patients with AV nodal reentrant tachycardia. Part Two: Pacing. 17. Cardiac pacing in Europe in 1992: a new survey. 18. The myocardium-electrode interface at the cellular level. 19. The myocardium-electrode interface at the macro level. 20. Unipolar versus bipolar leads. 21. Single lead VDD pacing: an update. 22. Substantial improvement of screw-in electrodes. 23. Physiological cardiac pacing: an individual objective. 24. Pacemaker syndrome during atrial-based pacing. 25. Dual chamber pacemaker therapy in cardiomyopathy. 26. DDD rate-responsive pacing: state of the art. 27. Heart rate response based on changes in central venous oxygen saturation, minute ventilation and body activity. 28. DDDR and atrial arrhythmia. 29. Holter and pacemaker diagnostics. 30. Clinical relevance of histograms in the follow-up of DDDR-pacemakers. 31. Holter and telemetry in pacemakers and ICDs: new developments. 32. Automatic measure of the interface capacitor and the total cardiac impedance. 33. Critical analysis of the different algorithms designed to protect the paced patient against atrial tachyarrhythmias in dual chamber pacing. 34. Mode switching in DDDR pacing. Part Three: Defibrillators. 35. Indication for ICD implantation and selection of patients: present and future. 36. The optimum tilt for defibrillation. 37. Cerebrovasomotor reactivity predicts tolerance to tiered therapy with implantable cardioverter-defribillators. 38. Clinical utility of telemetered electrograms in pacemakers and ICD's. 39. High patient acceptance for implantable cardioverter/defribillator (ICD); quality of life and patient acceptance. 40. Cardiac pacing and electrophysiology: how much technology do we need? 41. Medical technology assessment and reimbursement policy of implantable devices in Belgium: possibilities and limitations for the future. 42. Socio-economic aspects of implantable devices: can we afford new technology? Index.